What is the new maximum weekly dose of Wegovy approved in the UK?

The UK health regulator has approved a maximum weekly dose of up to 7.2 milligrams for Wegovy.

Who is eligible for the higher Wegovy dosage in Britain?

The higher dosage of Wegovy is approved exclusively for patients diagnosed with obesity in Britain.

Which company makes the drug Wegovy?

The weight-loss drug Wegovy is manufactured by Novo Nordisk.

Home / Health / UK Greenlights Max Wegovy Dose for Obesity Patients

UK Greenlights Max Wegovy Dose for Obesity Patients

16 Jan

•

Summary

Britain's health regulator approved a new maximum dose.
The approved dose is up to 7.2 milligrams per week.
This higher dose is specifically for patients with obesity.

UK Greenlights Max Wegovy Dose for Obesity Patients

The UK's health regulator has recently authorized a higher maximum dosage for Novo Nordisk's popular weight-loss medication, Wegovy. This approval permits a weekly dose of up to 7.2 milligrams, specifically targeting individuals diagnosed with obesity. This regulatory decision by the British health authority signifies a notable step in managing weight for patients who meet the specified criteria.

The development focuses on expanding treatment options for obesity, a condition that affects a significant portion of the population. The approved increase in Wegovy's dosage aims to potentially enhance its effectiveness for eligible patients, reinforcing its role as a key therapeutic tool in weight management.